Akums Drugs & Pharmaceuticals Ltd News

Akums secures patent for dual-action nausea drug for pregnant women

Akums receives DCGI approval for a dual-release Doxylamine-Pyridoxine tablet designed to relieve nausea and vomiting in pregnancy with reduced dosing frequency

Akums Drugs slips 3% after posting 66% decline in Q3 profits, rev down 7%

Akums Drugs reported a decline of 66 per cent year-on-year (Y-o-Y) to Rs 65.18 crore as compared to Rs 193.7 crore

Akums Drugs share plummets 6% after IT Department conducts tax searches

Akums Drugs and Pharmaceuticals share price slumped 6.57 per cent at Rs 585 a piece on the BSE in Wednesday's intraday trade

Akums announces new facility for lyophilized, sterile dosage manufacturing

Lyophilisation is the process of extracting water from drug particles at freezing temperatures, maintaining the drug's value and preserving the stability

Akums Drugs hits 10% upper circuit; gains 12% in two days; here's why

Under the agreement, Akums will receive a payment of 100 million euro upfront to support product development and secure European regulatory approvals for its oral liquid manufacturing unit

Akums Drugs signs agreement with leading Euro Co; share price gains 5%

Akums share price: Akums group will manufacture and supply multiple SKUs of Oral Liquid Formulation to be marketed in multiple European countries by the global Company